4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC
Clinical trial NCT05980702 · RECRUITING
Trial details
- NCT number
- NCT05980702
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2025-04-03
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.